MARKET NEWS

Novel Nuclear MicroRNA is Being Developed for the Treatment of Cardiovascular Disease
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation Products
Outlook Therapeutics Submits BLA to FDA for ONS-5010 as a Treatment for Wet AMD
Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
Cidara Therapeutics Announces Completion of Dosing the First Cohort of Healthy Volunteers in Phase 1 Trial
Qualigen Therapeutics Engages TD2 as Contract Research Organization for Preclinical Development

  FEATURED EDITORIAL

  COMPANY PROFILE

Proveris Scientific is an instrument and laboratory service company that creates today’s most advanced testing solutions for orally inhaled and nasal drug product (OINDP) drug development and manufacturing. As partners to our clients we, accelerate successful product development, and prevent late-stage development failures, realize significant savings in time and resources by streamlining testing workflows, evaluate the suitability of various OINDP delivery devices and optimize device parameters for maximum efficacy, and optimize testing variables to maintain batch-to-batch reproducibility, simplifying regulatory submissions. Click here for more.

For over 30 years, DDL has provided extraordinary service and specialized testing expertise to the medical device and pharmaceutical industries. Our reliable quality, responsive attention, and on-schedule completion for packaging, medical device, and combination products testing secures confidence in performance and safety while achieving regulatory compliance. DDL’s package testing services evaluate the strength and integrity of packaging systems before and after simulating the anticipated distribution and storage conditions that the systems may undergo. Packaging professionals use this combination of simulation and evaluation to validate package compliance with ASTM, ISO, ISTA and other accepted industry standards. DDL offers full service package testing in Eden Prairie, MN and Irvine, CA, and select package testing capabilities in Edison, NJ. Click here for more.

 

  EXCLUSIVE ONLINE CONTENT

 

Ocugen Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate

Ocugen Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate

Ocugen, Inc. recently announced the first patient has been dosed in the Phase 1/2 clinical trial of OCU400, a modifier gene therapy candidate for the treatment of retinitis pigmentosa….

Silo Pharma Enters Agreement With CRO for Pharmacokinetic Study

Silo Pharma Enters Agreement With CRO for Pharmacokinetic Study

Silo Pharma, Inc. recently announced it has entered into an agreement with Frontage Laboratories, a CRO providing integrated, science-driven, product development services throughout the….

Vyant Bio & OrganoTherapeutics Announce Strategic Collaboration 

Vyant Bio & OrganoTherapeutics Announce Strategic Collaboration 

Vyant Bio, Inc. and OrganoTherapeutics recently announced they have entered into a collaboration agreement to work toward accelerating the discovery of drugs for the treatment of….

Mapi Pharma Receives US Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive MS With a Sustained-Release Glatiramer Acetate Depot

Mapi Pharma Receives US Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive MS With a Sustained-Release Glatiramer Acetate Depot

Mapi Pharma Ltd. recently announced it has been granted US Patent No. 11,167,003 titled Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis….

eTheRNA Manufacturing Announces New LNP Formulation Development & Production Service

eTheRNA Manufacturing Announces New LNP Formulation Development & Production Service

eTheRNA Manufacturing recently introduced a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early preclinical development of RNA-based….

Owen Mumford & Noble International Announce Collaboration

Owen Mumford & Noble International Announce Collaboration

Owen Mumford Pharmaceutical Services recently announces its alliance with Noble International, an Aptar Pharma company and world leader in providing drug delivery….

  WHITEPAPERS & WEBINARS

On-Demand Webinar: How to Safely Handle Your Antibody Drug Conjugate

On-Demand Webinar: How to Safely Handle Your Antibody Drug Conjugate

Antibody Drug Conjugates (ADCs) have a highly specific mechanism of action which is an advantage for the treatment of several oncology indications…..

Celanese Live Webinar: Engineering Drug Delivery to Improve Therapeutic Outcomes

Celanese Live Webinar: Engineering Drug Delivery to Improve Therapeutic Outcomes

Celanese and ThermoFisher Scientific have partnered together to present the value of the VitalDose® EVA drug delivery platform and manufacturing through Hot Melt Extrusion (HME) on September 9, 2021.

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

The need for flexible solutions for potent product handling is increasing. We’ll discuss the proven benefits of aseptic isolator systems in sterile environments and take a look at real feedback from real customers of ours in an upcoming webinar on Tuesday, November 16th at 11:00 AM EST.

  WHITEPAPERS & WEBINARS

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

Are you prepared for the HFA phasedown? With many industries switching to more environmentally friendly propellants, pMDI developers need to be ready. Recipharm explore alternative technologies to HFA propellants, and how the devices and formulations can be optimized to ensure …

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

What techniques should manufacturers employ when working with low-dose drug products?

By: Thomas Daggs, MBA, Vice President, Product Development & Quality Control, and Angelo Consalvo, Director of Manufacturing, Enteris BioPharma

Anyone who takes an oral tablet medication – whether prescribed …

eBOOK: Antibody Production

eBOOK: Antibody Production

Antibody production is a multi-step complex process and generating reproducible antibodies is highly critical for immunoassays-based research, immunodiagnostics, and immunotherapy. Antibodies’ reproducibility is driven by their specificity and several other factors ranging from antibody design to target validation. Our Antibody …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 13 – Prefilled Syringes
April 20 – Inhalation Delivery